OptimizeRx Corporation

Equities

OPRX

US68401U2042

Internet Services

Market Closed - Nasdaq 04:30:01 2024-05-03 pm EDT 5-day change 1st Jan Change
10.62 USD -0.75% Intraday chart for OptimizeRx Corporation +20.68% -25.79%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M MT
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 EPS $0.26 MT
OptimizeRx Corporation Reiterates Financial Guidance for the Full Year 2024 CI
OptimizeRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
JMP Securities Initiates Coverage on OptimizeRx With Market Perform Rating, $15 Price Target MT
OptimizeRx Expected to Meet 2024 Guidance, RBC Says; Shares Drop MT
Transcript : OptimizeRx Corporation, Q4 2023 Earnings Call, Mar 28, 2024
Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023. CI
OptimizeRx Corp. Powers Walmart's ?Specialty Pharmacies of the Community? Outreach Effort CI
OptimizeRx Corporation Announces Changes to its Board CI
RBC Adjusts OptimizeRx's Price Target to $17 From $14, Keeps Outperform Rating MT
OptimizeRx Shares Jump as Preliminary 2023 Revenue Tops Guidance MT
OptimizeRx Corporation Revises Earnings Guidance for the Year 2023 CI
Barclays Starts OptimizeRx With Equalweight Rating, $15 Price Target MT
Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023. CI
Transcript : OptimizeRx Corporation, Q3 2023 Earnings Call, Nov 06, 2023
OptimizeRx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q3 Revenue $16.3M, vs. Street Est of $15.1M MT
OptimizeRx Corporation Provides Earnings Guidance for the Year 2024 CI
OptimizeRx Corporation Increases Earnings Guidance for the Year 2023 CI
North American Morning Briefing : Stocks Look to -2- DJ
OptimizeRx Corporation completed the acquisition of Healthy Offers, Inc. from a group of shareholders. CI
Optimizerx Corporation to Change the Designation of Stephen L. Silvestro from Chief Commercial Officer to President CI
Transcript : Healthy Offers, Inc., OptimizeRx Corporation - M&A Call
OptimizeRx Agrees to Acquire Medicx Health for $95 Million; Issues Q3 Non-GAAP Net Income, Revenue Expectations MT
Chart OptimizeRx Corporation
More charts
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
10.62 USD
Average target price
16.17 USD
Spread / Average Target
+52.23%
Consensus
  1. Stock Market
  2. Equities
  3. OPRX Stock
  4. News OptimizeRx Corporation
  5. Barclays Starts OptimizeRx With Equalweight Rating, $15 Price Target